Jutba, Feliciano .

HRN: 05-51-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/20/2023
07/30/2023
IV
500mg
Q8hr
Empiric
Waiting Final Action 
07/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/20/2023
07/27/2023
IV
4.5g
Q8hr
Empiric
Waiting Final Action 
08/03/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/03/2023
08/09/2023
PO
5ml
BID
Oral Thrush
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: